Your browser doesn't support javascript.
loading
Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Joseph, Kurian; Balushi, Mustafa Al; Ghosh, Sunita; Stenson, Trevor; Abraham, Aswin; Elangovan, Arun; Warkentin, Heather; Paulson, Kim; Tankel, Keith; Usmani, Nawaid; Severin, Diane; Schiller, Dan; Wong, Clarence; Mulder, Karen; Doll, Corinne; King, Karen; Nijjar, Tirath.
Afiliação
  • Joseph K; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada. Electronic address: kurian.joseph@albertahealthservices.ca.
  • Balushi MA; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Ghosh S; Division of Medical Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Stenson T; Alberta Cancer Clinical Trials, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Abraham A; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Elangovan A; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Warkentin H; Alberta Cancer Clinical Trials, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Paulson K; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Tankel K; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Usmani N; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Severin D; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Schiller D; Division of Medical Physics, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Wong C; Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Canada; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.
  • Mulder K; Division of Medical Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Doll C; Division of Radiation Oncology, Department of Oncology, University of Calgary & Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • King K; Division of Medical Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Nijjar T; Division of Radiation Oncology, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, Alberta, Canada.
Int J Radiat Oncol Biol Phys ; 117(2): 434-445, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37148982
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Radioterapia de Intensidade Modulada / Incontinência Fecal / Sobreviventes de Câncer Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Radioterapia de Intensidade Modulada / Incontinência Fecal / Sobreviventes de Câncer Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article